| [1] |
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3):209-249.
|
| [2] |
Gao YX, Yang TW, Yin JM, et al. Progress and prospects of biomarkers in primary liver cancer (Review)[J]. Int J Oncol, 2020, 57(1):54-66.
|
| [3] |
Liu D, Song T. Changes in and challenges regarding the surgical treatment of hepatocellular carcinoma in China[J]. Biosci Trends, 2021, 15(3):142-147.
|
| [4] |
Ruiz-Margáin A, Román-Calleja BM, Moreno-Guillén P, et al. Nutritional therapy for hepatocellular carcinoma[J]. World J Gastrointest Oncol, 2021, 13(10):1440-1452.
|
| [5] |
Park SH, Lee S, Song JH, et al. Prognostic significance of body mass index and prognostic nutritional index in stageⅡ/Ⅲ gastric cancer[J]. Eur J Surg Oncol, 2020, 46(4 Pt A):620-625.
|
| [6] |
Zhang J, Zhang Y, Yv X, et al. Prognostic value of combined preoperative prognostic nutritional index and neutrophil to lymphocyte ratio in esophageal squamous cell carcinoma[J]. Transl Cancer Res, 2020, 9(9):5117-5127.
|
| [7] |
Tokunaga R, Sakamoto Y, Nakagawa S, et al. Prognostic nutritional index predicts severe complications, recurrence, and poor prognosis in patients with colorectal cancer undergoing primary tumor resection[J]. Dis Colon Rectum, 2015, 58(11):1048-1057.
|
| [8] |
朱润, 蒋圣军, 隋韬, 等. 血液炎症-营养指标在晚期肝癌患者的预后价值研究[J]. 结肠肛门外科, 2021, 27(S1):45-46.
|
| [9] |
覃莉, 杨小玲, 李川, 等. PLR和PNI联合评分评估肝细胞肝癌患者肝切除术后复发和生存期的价值[J]. 四川大学学报(医学版), 2018, 49(4):645-648.
|
| [10] |
梁荣朴, 叶林森, 张杰滨, 等. 术后预后营养指数在肝细胞癌患者预后中的价值[J/CD].中华肝脏外科手术学电子杂志, 2018, 7(2):138-142.
|
| [11] |
Imai D, Maeda T, Shimokawa M, et al. Prognostic nutritional index is superior as a predictor of prognosis among various inflammation-based prognostic scores in patients with hepatocellular carcinoma after curative resection[J]. Hepatol Res, 2020, 50(1):101-109.
|
| [12] |
Chan AW, Chan SL, Wong GL, et al. Prognostic nutritional index (PNI) predicts tumor recurrence of very early/early stage hepatocellular carcinoma after surgical resection[J]. Ann Surg Oncol, 2015, 22(13):4138-4148.
|
| [13] |
Okamura Y, Sugiura T, Ito T, et al. The optimal cut-off value of the preoperative prognostic nutritional index for the survival differs according to the TNM stage in hepatocellular carcinoma[J]. Surg Today, 2017, 47(8):986-993.
|
| [14] |
Campbell PT, Newton CC, Freedman ND, et al. Body mass index, waist circumference, diabetes, and risk of liver cancer for U.S. adults[J]. Cancer Res, 2016, 76(20):6076-6083.
|
| [15] |
Sohn W, Lee HW, Lee S, et al. Obesity and the risk of primary liver cancer: a systematic review and meta-analysis[J]. Clin Mol Hepatol, 2021, 27(1):157-174.
|
| [16] |
毕华强, 刘辉, 张曦, 等. 体重指数对于肝癌患者肝切除术后预后的影响[J]. 中国普外基础与临床杂志, 2016, 23(11):1325-1330.
|
| [17] |
谢锐, 梁红亮, 杨舒钧, 等. 体质量指数与肝癌患者临床病理特征及预后关系[J]. 临床军医杂志, 2020, 48(3):347-348, 351.
|
| [18] |
Shirata C, Hasegawa K, Kokudo T, et al. Surgical site infection after hepatectomy for hepatocellular carcinoma[J]. Dig Surg, 2018, 35(3):204-211.
|
| [19] |
秦明慧, 王静, 张玉佩, 等. 高体重指数对手术切除术后原发性肝癌患者常见并发感染影响的meta分析[J]. 现代医药卫生, 2020, 36(17):2693-2696, 2703.
|
| [20] |
李萍, 刘文红, 赵萌, 等. 原发性肝癌肝动脉化疗栓塞术术前营养风险筛查的意义及个体化营养干预效果分析[J]. 中华全科医学, 2021, 19(7):1087-1090.
|
| [21] |
Park YE, Kim BK, Park JY, et al. Gamma-glutamyl transpeptidase-to-platelet ratio is an independent predictor of hepatitis B virus-related liver cancer[J]. J Gastroenterol Hepatol, 2017, 32(6):1221-1229.
|
| [22] |
Hu Z, Chen H, Chen S, et al. The value of neutrophil to lymphocyte ratio and gamma-glutamyl transpeptidase to platelet ratio in patients with hepatocellular carcinoma[J]. Medicine, 2019, 98(9):e14749.
|
| [23] |
Yang D, Wu H, Nong W, et al. A new model based on gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts prognostic outcome after curative resection of solitary hepatocellular carcinoma[J]. Clin Res Hepatol Gastroenterol, 2021, 45(5):101509.
|
| [24] |
张宇, 吴丽君, 马良, 等. 术前血清γ-谷氨酰转肽酶/血小板比值指数与乙肝病毒相关性肝细胞癌术后患者预后的关系[J]. 天津医药, 2017, 45(5):489-492.
|
| [25] |
Shimada S, Kamiyama T, Orimo T, et al. Long-term prognostic factors of patients with hepatocellular carcinoma who survive over 10 years after hepatectomy[J]. J Surg Oncol, 2020, 121(8):1209-1217.
|
| [26] |
徐清泉. 前白蛋白、白蛋白、总胆红素、总胆汁酸及胆碱酯酶在肝脏疾病诊断中的应用价值[J]. 中国药物经济学, 2017, 12(12):120-122.
|
| [27] |
Ren M, Li J, Xue R, et al. Liver function and energy metabolism in hepatocellular carcinoma developed in patients with hepatitis B-related cirrhosis[J]. Medicine, 2019, 98(19):e15528.
|
| [28] |
黄涛, 梁廷波. 肝癌患者围手术期血清胆碱酯酶水平评估手术预后的意义[J]. 浙江医学, 2006, 28(9):704-706.
|
| [29] |
王肖引. 血清CHE、TBA与ADA水平变化在肝病患者临床诊断及预后判断中的应用价值[J]. 医药论坛杂志, 2017, 38(6):168-169.
|
| [30] |
杨波. 不同肝病患者血清胆碱酯酶与前白蛋白、视黄醇结合蛋白、超敏C-反应蛋白表达水平及其临床意义[J]. 实用医院临床杂志, 2015, 12(6):73-76.
|
| [31] |
彭秉信, 成海恩, 金亚平, 等. 肝功能损伤患者血清视黄醇结合蛋白的检测[J]. 检验医学与临床, 2012, 9(6):706-707.
|
| [32] |
姜宇海. 肝脏疾病患者血清中CHE、RBP、TBA、ADA、mAST的变化[J]. 现代预防医学, 2012, 39(24):6464-6465.
|
| [33] |
李晨琪, 顾杨娟, 葛瑞良, 等. 原发性肝癌患者术前营养相关指标与患者主观整体评估评分的相关性研究[J]. 海军医学杂志, 2021, 42(6):727-731.
|
| [34] |
陈焕伟, 梁力建, 甄作均. 血清快速转化蛋白测定在肝功能评估中的临床意义[J]. 中华肝胆外科杂志, 2001, 7(7):403-405.
|
| [35] |
孟祥洁. 血清视黄醇结合蛋白、前白蛋白、胆碱脂酶水平联合检测对慢性肝炎患者的诊断价值[J]. 河南医学研究, 2020, 29(15):2843-2845.
|